Stock Research: Repligen

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Repligen

NasdaqGS:RGEN US7599161095
71
  • Value
    63
  • Growth
    71
  • Safety
    Safety
    4
  • Combined
    36
  • Sentiment
    95
  • 360° View
    360° View
    71
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Repligen Corporation develops and commercializes bioprocessing technologies and systems for the life sciences industry. It focuses on Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins. Its products are used in process development, manufacturing, and quality control of biological drugs. In the last fiscal year, the company had a market cap of $6737 million, profits of $319 million, and revenue of $634 million, with 1778 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 71 (better than 71% compared with alternatives), overall professional sentiment and financial characteristics for the stock Repligen are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Repligen. The consolidated Growth Rank has a good rank of 71, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 71% of competitors in the same industry. The consolidated Safety Rank at 63 means that the company has a financing structure that is safer than 63% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 95, which means that professional investors are more optimistic about the stock than for 95% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 4, meaning that the share price of Repligen is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 96% of alternative stocks in the same industry. ...read more

more
Index
NASDAQ
S&P MIDCAP
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
4 6 1 5
Growth
71 65 33 49
Safety
Safety
63 88 78 67
Sentiment
95 65 96 95
360° View
360° View
71 77 57 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
75 51 74 66
Opinions Change
76 50 72 35
Pro Holdings
n/a 37 66 97
Market Pulse
94 77 78 80
Sentiment
95 65 96 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
4 6 1 5
Growth
71 65 33 49
Safety Safety
63 88 78 67
Combined
36 71 22 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
5 5 12 6
Price vs. Earnings (P/E)
5 13 9 29
Price vs. Book (P/B)
38 37 37 37
Dividend Yield
1 1 1 1
Value
4 6 1 5
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
61 59 27 55
Profit Growth
52 32 21 88
Capital Growth
67 80 55 4
Stock Returns
47 47 69 59
Growth
71 65 33 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
54 51 47 50
Refinancing
47 35 23 27
Liquidity
49 88 98 72
Safety Safety
63 88 78 67

Similar Stocks

Discover high‑ranked alternatives to Repligen and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.